Acute lymphoblastic leukaemia trials in Poland
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Katowice, Krakow, Warsaw, Wroclaw
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 3Taking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Wroclaw
- Age
- 1 year to 64 years
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - Phase 2/3Taking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Poznan
- Age
- 3 months to 25 years
- People
- 1,000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Bialystok, Bydgoszcz, Chorzów, Cracow, Gdansk, Katowice, Kielce, Lodz, Lublin, Olsztyn, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zabrze
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 3Taking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Gliwice, Katowice, Krakow, Skorzewo (Poznan), Torun
- Age
- 18 years and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - Phase 1Taking peoplePhase 1 trial of trametinib and gilteritinib for the treatment of relapsed or refractory acute leukemia patients
- Where
- Gdansk, Katowice, Poznan, Warsaw, Wrocław
- Age
- 18 years and over
- People
- 54
- Run by
- Instytut Hematologii I Transfuzjologii
See details and how to join2024-518301-18-00 · EU 2024-518301-18-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Bydgoszcz, Wroclaw
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Bydgoszcz, Krakow, Lublin, Poznan, Wroclaw
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 2Taking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Lodz, Lublin, Wroclaw
- Age
- Up to 17 years
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - Phase 2/3Taking peopleSingle-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.
- Where
- Bialystok, Bydgoszcz, Cracow, Gdansk, Katowice, Kielce, Lodz, Lublin, Olsztyn, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zabrze
- Age
- Up to 17 years
- People
- 25
- Run by
- Medical University Of Lodz
See details and how to join2024-518316-39-00 · EU 2024-518316-39-00